Literature DB >> 26901160

Intrinsic Disorder to Order Transitions in the Scaffold Phosphoprotein P from the Respiratory Syncytial Virus RNA Polymerase Complex.

María G Noval1, Sebastian A Esperante1, Ivana G Molina1, Lucía B Chemes1, Gonzalo de Prat-Gay1,2.   

Abstract

Intrinsic disorder is at the center of biochemical regulation and is particularly overrepresented among the often multifunctional viral proteins. Replication and transcription of the respiratory syncytial virus (RSV) relies on a RNA polymerase complex with a phosphoprotein cofactor P as the structural scaffold, which consists of a four-helix bundle tetramerization domain flanked by two domains predicted to be intrinsically disordered. Because intrinsic disorder cannot be reduced to a defined atomic structure, we tackled the experimental dissection of the disorder-order transitions of P by a domain fragmentation approach. P remains as a tetramer above 70 °C but shows a pronounced reversible secondary structure transition between 10 and 60 °C. While the N-terminal module behaves as a random coil-like IDP in a manner independent of tetramerization, the isolated C-terminal module displays a cooperative and reversible metastable transition. When linked to the tetramerization domain, the C-terminal module becomes markedly more structured and stable, with strong ANS binding. Therefore, the tertiary structure in the C-terminal module is not compact, conferring "late" molten globule-like IDP properties, stabilized by interactions favored by tetramerization. The presence of a folded structure highly sensitive to temperature, reversibly and almost instantly formed and broken, suggests a temperature sensing activity. The marginal stability allows for exposure of protein binding sites, offering a thermodynamic and kinetic fine-tuning in order-disorder transitions, essential for the assembly and function of the RSV RNA polymerase complex.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26901160     DOI: 10.1021/acs.biochem.5b01332

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  New Insights into Structural Disorder in Human Respiratory Syncytial Virus Phosphoprotein and Implications for Binding of Protein Partners.

Authors:  Nelson Pereira; Christophe Cardone; Safa Lassoued; Marie Galloux; Jenna Fix; Nadine Assrir; Ewen Lescop; François Bontems; Jean-François Eléouët; Christina Sizun
Journal:  J Biol Chem       Date:  2016-12-28       Impact factor: 5.157

2.  Tetramerization of Phosphoprotein is Essential for Respiratory Syncytial Virus Budding while its N Terminal Region Mediates Direct Interactions with the Matrix Protein.

Authors:  Monika Bajorek; Marie Galloux; Charles-Adrien Richard; Or Szekely; Rina Rosenzweig; Christina Sizun; Jean-Francois Eleouet
Journal:  J Virol       Date:  2021-01-06       Impact factor: 5.103

3.  Structural dissection of human metapneumovirus phosphoprotein using small angle x-ray scattering.

Authors:  Max Renner; Guido C Paesen; Claire M Grison; Sébastien Granier; Jonathan M Grimes; Cédric Leyrat
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

Review 4.  Transient Secondary Structures as General Target-Binding Motifs in Intrinsically Disordered Proteins.

Authors:  Do-Hyoung Kim; Kyou-Hoon Han
Journal:  Int J Mol Sci       Date:  2018-11-15       Impact factor: 5.923

Review 5.  Pneumoviral Phosphoprotein, a Multidomain Adaptor-Like Protein of Apparent Low Structural Complexity and High Conformational Versatility.

Authors:  Christophe Cardone; Claire-Marie Caseau; Nelson Pereira; Christina Sizun
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

6.  Structure of the Respiratory Syncytial Virus Polymerase Complex.

Authors:  Morgan S A Gilman; Cheng Liu; Amy Fung; Ishani Behera; Paul Jordan; Peter Rigaux; Nina Ysebaert; Sergey Tcherniuk; Julien Sourimant; Jean-François Eléouët; Priscila Sutto-Ortiz; Etienne Decroly; Dirk Roymans; Zhinan Jin; Jason S McLellan
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.